Trexquant Investment’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-74,867
Closed -$1.36M 1833
2021
Q4
$1.36M Buy
74,867
+50,100
+202% +$1.08M 0.08% 306
2021
Q3
$484K Buy
24,767
+11,949
+93% +$454K 0.04% 553
2021
Q2
$574K Sell
12,818
-1,181
-8% -$54.7K 0.05% 454
2021
Q1
$703K Buy
+13,999
New +$954K 0.06% 387

Other funds holding CELL

Trexquant Investment's CELL Position: Q1 2022 in Review

Trexquant Investment sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 74,867 shares — an estimated $1.36M sold.

Trexquant Investment first reported a position in CELL in Q1 2021 and held it in 4 quarters. The position peaked at $1.36M in Q4 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Trexquant Investment reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Trexquant Investment sold 74,867 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $1.36M.
  • Trexquant Investment first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Trexquant Investment's PhenomeX Inc. Common Stock position peaked at $1.36M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.